OncoResponse
0 followers
‌
OncoResponse leverages the power of the human immune system to identify fully human monoclonal antibodies and discover novel targets that will lead to the development of antibody-derived therapeutics for the treatment of cancer.
Industries
Headquarters
Employees
Links
Org chart
Clifford J. Stocks
Chief Executive Officer
Clifford J. Stocks
Collapse
Chris Russell
Chief Financial Officer
Kamal D. Puri
Chief Scientific Officer
Myriam Bouchlaka
Director Immuno-Oncology
